India to Taiwan Pharmaceutical Export (2026) — $36.6M, 100 Suppliers | TransData Nexus

India to Taiwan Pharmaceutical Export (2026) — $36.6M, 100 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Taiwan

#	Formulation	Value	Share
1	Pharmaceutical Products - Allegra 180mgtablets	$11.7M	32.0%
2	Harmless Medicines, Valacyclovir Mylan 500 MG 42bl Tablets (10593 Packs)	$2.9M	7.8%
3	Abatacept 125/pfs(qty:1247 Pfs)	$798.4K	2.2%
4	Lanclean Chewable Tablets 750 MG Lanthanum Carbonate Chewable Tablets 750mg	$358.7K	1.0%
5	Abiranat 250 MG Tablets 120s (1200x120s)(appendix 4r, Rodtep Entry No:10112)(ot…	$287.2K	0.8%
6	Finpecia 1mg Tablets (finasteride 1mg) ( Inv. Qty. 62631 Pack 10 X 10's = 62631…	$259.6K	0.7%
7	Finpecia 1mg Tablets (finasteride 1mg) ( Inv. Qty. 62394 Pack 10 X 10's = 62394…	$258.7K	0.7%
8	Finpecia 1mg Tablets (finasteride 1mg) 62349 Pack 10 X 10's	$258.5K	0.7%
9	Finpecia 1mg Tablets (finasteride 1mg) 62222 Pack 10 X 10's	$257.9K	0.7%
10	Vigabatrin Oral Solution	$250.7K	0.7%
11	Finpecia 1mg Tablets (finasteride 1mg) ( Inv. Qty. 206850 Pack 3 X 10's =620550…	$244.4K	0.7%
12	Finpecia 1mg Tablets (finasteride 1mg) ( Inv. Qty. 205590 Pack 3 X 10's = 61677…	$242.9K	0.7%
13	Pharmaceutical Products - Allegra 60mg T	$215.9K	0.6%
14	Pharma Rancad Er Tablets 500mg Tsh Tw Ranolazine Extended Release 500mg 1boxx2x…	$207.6K	0.6%
15	Pharmaceutical Products Allegra 60mg Tablets 48861 Pack X 10 X 10	$207.2K	0.6%

India exports 20+ pharmaceutical formulations to Taiwan with a combined trade value of $36.6M. Key products include Valacyclovir ($2.9M), Carboplatin ($200K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 2,710 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Taiwan Trade Routes

1Valacyclovir$2.9M 2Carboplatin$200K

These are the top pharmaceutical products exported from India to Taiwan, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Taiwan buyers, regulatory requirements, and logistics for that specific product corridor. Products include Valacyclovir ($2.9M), Carboplatin ($200K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Taiwan

1Sanofi India Limited

$12.5M

2Mylan Laboratories Limited

$3.5M

3Fresenius Kabi Oncology Limited

$2.2M

4Vinayak Pharma Corp

$2.0M

5Gmsanjivani Llp

Port Analysis — India to Taiwan Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA0.3%

DELHI AIR3.1%

NHAVA SHEVA SEA (INNSA1)1.9%

SAHAR AIR25.8%

SAHAR AIR CARGO ACC (INBOM4)38.1%

Taiwan Import Ports

TAIPEI81.4%

Keelung (Chilung)2.0%

Taipei0.6%

KAOHSIUNG0.5%

KEELUNG (CHILUNG)1.7%

Trade Statistics

Total Value$36.6M

Shipments2,710

Indian Exporters100

Taiwan Buyers200

Avg Shipment$14K

Products1,711

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Taiwan Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Taiwan has experienced significant growth over the past decade. In 2022, the total export value from India to Taiwan was $36.6 million USD, encompassing 2,710 shipments from 100 Indian exporters to 200 Taiwanese buyers. This expansion reflects the strengthening of bilateral trade relations and the increasing demand for quality pharmaceutical products in Taiwan. The average shipment value stood at $14,000, indicating a robust and consistent trade flow between the two nations.

2India's Market Position

India holds a substantial share in Taiwan's pharmaceutical import market, positioning itself as a key supplier of finished pharmaceutical formulations. The strategic importance of this relationship is underscored by the diverse range of products exported, catering to various therapeutic needs in Taiwan. This market presence is further solidified by the adherence to international quality standards, enhancing India's reputation as a reliable pharmaceutical exporter.

3Recent Developments

Between 2024 and 2026, the India-Taiwan pharmaceutical trade witnessed notable developments. In February 2026, bilateral trade reached a record NT$391.55 billion (approximately US$12.51 billion), marking a 17.95% increase from the previous year. This surge was driven by heightened industrial cooperation and demand for Taiwanese chips, reflecting a broader trend of strengthening economic ties. While this growth is commendable, it also presents opportunities for Indian pharmaceutical exporters to further penetrate the Taiwanese market by aligning with Taiwan's evolving industrial needs. (taiwannews.com.tw)

Taiwan Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Taiwan must comply with the Good Manufacturing Practice (GMP) standards set by the World Health Organization (WHO). The registration process involves submitting a comprehensive dossier, typically in the Common Technical Document (CTD) or electronic Common Technical Document (eCTD) format, which includes detailed information on the product's quality, safety, and efficacy. Bioequivalence studies are often required to demonstrate that the generic product performs similarly to the innovator drug. The timeline for registration can vary, but it generally spans several months, depending on the complexity of the product and the completeness of the submitted documentation.

2GMP & Facility Requirements

Taiwan mandates that foreign pharmaceutical manufacturers adhere to its GMP standards, which are aligned with international practices, including those of the Pharmaceutical Inspection Co-operation Scheme (PIC/S). The inspection process involves a thorough evaluation of manufacturing facilities to ensure compliance with these standards. Mutual recognition agreements between Taiwan and other countries may facilitate the acceptance of GMP certifications from recognized authorities, potentially streamlining the approval process for Indian manufacturers. However, Taiwanese authorities retain the right to conduct on-site inspections to verify compliance. (fda.gov.tw)

3Import Documentation

To import pharmaceutical products into Taiwan, Indian exporters must obtain an import drug permit license from the Taiwanese Food and Drug Administration (TFDA). Required documentation includes a Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and proof of GMP compliance. Customs procedures involve detailed inspections to ensure that imported pharmaceuticals meet Taiwan's stringent quality standards. Non-compliance can result in penalties, including the return or destruction of the products.

EXPORT_TRENDS

TransData Nexus Research · Taiwan regulatory databasesMar 2026

FAQ — India to Taiwan Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Taiwan?

India exported pharmaceuticals worth $36.6M to Taiwan across 2,710 verified shipments.

Who are the top Indian pharmaceutical exporters to Taiwan?

1. SANOFI INDIA LIMITED — $12.5M. 2. MYLAN LABORATORIES LIMITED — $3.5M. 3. FRESENIUS KABI ONCOLOGY LIMITED — $2.2M. Total: 100 suppliers.

Which companies in Taiwan import pharmaceuticals from India?

1. DKSH TAIWAN LTD — $13.8M. 2. VIATRIS PHARMACEUTICALS CO. LT,, — $2.9M. 3. TO THE- — $1.7M. 200 buyers total.

What pharmaceutical products does India export most to Taiwan?

1. Pharmaceutical Products - Allegra 180mgtablets ($11.7M, 32.0%); 2. Harmless Medicines, Valacyclovir Mylan 500 MG 42bl Tablets (10593 Packs) ($2.9M, 7.8%); 3. Abatacept 125/pfs(qty:1247 Pfs) ($798.4K, 2.2%); 4. Lanclean Chewable Tablets 750 MG Lanthanum Carbonate Chewable Tablets 750mg ($358.7K, 1.0%); 5. Abiranat 250 MG Tablets 120s (1200x120s)(appendix 4r, Rodtep Entry No:10112)(ot… ($287.2K, 0.8%)

Which ports handle pharmaceutical shipments from India to Taiwan?

Export: NHAVA SHEVA SEA, DELHI AIR, NHAVA SHEVA SEA (INNSA1), SAHAR AIR, SAHAR AIR CARGO ACC (INBOM4). Import: TAIPEI, Keelung (Chilung), Taipei, KAOHSIUNG, KEELUNG (CHILUNG).

Why does Taiwan import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $36.6M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Taiwan?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Taiwan pharmaceutical trade?

$13.5K per consignment across 2,710 shipments.

How many Indian pharmaceutical companies export to Taiwan?

100 Indian companies. Largest: SANOFI INDIA LIMITED with $12.5M.

How can I find verified Indian pharmaceutical suppliers for Taiwan?

TransData Nexus covers 100 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Taiwan identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 2,710 verified shipments from 100 Indian exporters to 200 Taiwan buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

100 Exporters

200 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Taiwan Pharmaceutical Export

Top Pharmaceutical Formulations — India to Taiwan

Top Pharmaceutical Products — India to Taiwan Trade Routes

Top Indian Exporters to Taiwan

Port Analysis — India to Taiwan Pharmaceutical Shipments

Indian Export Ports

Taiwan Import Ports

Trade Statistics

Other Destinations

India–Taiwan Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

3Recent Developments

Top Taiwan Buyers from India

Product Routes

Full Dataset Access

Taiwan Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Taiwan

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Taiwan

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Taiwan Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Taiwan for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Taiwan

1Competing Origins

2India's Competitive Edge

3Challenges & Threats